Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomised controlled trial

Lancet

Volumn 353, Issue 9171, 1999, Pages 2179-2184

  Taylor, D Wayne ^a   Barnett, Henry J M ^b,c   Haynes, R Brian ^a   Ferguson, Gary G ^c   Sackett, David L ^d   Thorpe, Kevin E ^a   Simard, Denis ^e   Silver, Frank L ^f   Hachinski, Vladimir ^c   Clagett, G Patrick ^g   Barnes, R ^h   Spence, J David ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LAVAL UNIVERSITY   (Canada)

^f TORONTO WESTERN HOSPITAL   (Canada)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SURGICAL RISK; TRANSIENT ISCHEMIC ATTACK;

EID: 0033606533     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05388-X     Document Type: Article

References (22)

1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 325:1991;445-453.
2. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 337:1991;1235-1243.
3. Barnett HJM, Taylor DW, Eliasziw M, et al, for the North American Symptomatic Carotid Endarterectomy Trial. The benefit of carotid endarterectomy in symptomatic patients with moderate and severe stenosis. N Engl J Med 1998; 339:1415-25.
4. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial. Lancet. 1998; 351: 1379-87.
5. Rothwell P.M., Slattery J., Warlow C.P. A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. Stroke. 27:1996;266-269.
6. Kozak LJ, Owings MF. Ambulatory and inpatient procedures in the United States 1995. National Center for Health Statistics. Vital Health Stat 13 1998; 135: 1-116.
7. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 308:1994;83-108.
8. Collaborative overview of randomised trials of antiplatelet therapy, II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ. 308:1994;159-168.
9. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 299:1978;53-59.
10. O'Brien J.R., Etherington M.D. How much aspirin? Thromb Haemost. 64:1990;486.
11. de Haan R., Limburg M., Bossuyt P., van der Meulen J., Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke. 26:1995;2027-2030.
12. Weiss H.J., Aledort L.M. Impaired platelet/connective-tissue reaction in man after aspirin ingestion. Lancet. 2:1967;495-497.
13. Harrison M.J.G., Marshall J., Meadows J.C., Russell R.W.R. Effect of aspirin in amaurosis fugax. Lancet. xx:1971;743-744.
14. Kuster L.J., Frolich J.G. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and PAF following low dose ASA in man. Prostaglandins Leukotrienes Med. 32:1986;415.
15. Tohgi H., Konno S., Tamura K.et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 23:1992;1400-1403.
16. Fields W.S., Lemak N.A., Frankowski R.F., Hardy R.J. Controlled trial of aspirin in cerebral ischemia. Stroke. 8:1977;301-316.
17. Bousser M.G., Eschwege E., Haguenau M.et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 14:1983;5-14.
18. Guiraud-Chaumeil B., Rascol A., David J.L., Boneu B., Clanet M., Bierme R. Prévention des récidives des accidents vasculaires cérébraux ischémiques par les anti-agrégants plaquettaires: résultats d'un essai thérapeutique contrôlé de 3 ans. Rev Neurol (Paris). 138:1982;367-385.
19. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 54:1991;1044-1054.
20. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxix after cerebrovascular ischaemic events. Lancet. 338:1991;1345-1349.
21. Findings from the aspirin component of the ongoing physicians health study. N Engl J Med. 318:1988;262-264.
22. Dyken, ML. The Willis lecture: controversies in stroke - past and present. Presented at 18th International Joint Conference on Stroke and Cerebral Circulation. Miami: February 11, 1993.